Other than IL-2, IL-18 was also found to be effective to induce the NK cell activity and the expression of CD107a degranulation marker both in metastatic melanoma and control, when used in combination with IL-12 in peripheral blood mononuclear cells from both groups [48]. Here, IL2 is linked to metastatic melanoma.